Udawela, M.
Scarr, E.
Boer, S.
Um, J. Y.
Hannan, A. J.
McOmish, C.
Felder, C. C.
Thomas, E. A.
Dean, B.
Article History
Received: 4 December 2016
Revised: 9 March 2017
Accepted: 21 March 2017
First Online: 19 April 2017
Competing Interests
: A/Prof Scarr received an honorarium from Astra-Zeneca and travel support from GSK. Prof Dean received travel support from GSK and honoraria from Pfizer, Eli Lilly and MSD. Prof Felder is an employee of Eli Lilly & Co. The other authors declare that they have no competing interests.